Skip to content

Gm1 Gangliosidosis Type I With Cardiac Involvement C1968748

Published: July 22, 2026Updated: August 20, 2026

A variant of GM1 with additional heart complications. It affects children with both neurological and cardiac symptoms. Management addresses multiple organ systems.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G31.82
ICD-11
8A00.0
Body system
neurologic
Severity
fatal
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Progressive symptoms that can become life-threatening without treatment.

Seek immediate medical attention if symptoms worsen.

!

Cardiomyopathy

!

Seizures

Developmental delay

(neurologic)

Hypotonia

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Cardiac failure management

Comprehensive cardiac care including diuretics, ACE inhibitors, and other heart failure medications as cardiac involvement progresses in type I variant.

medication
2

Outpatient procedure with monitoring

Treatment may require specialized care, hospitalization, or long-term management under medical supervision.

procedure
3

Cardiac surveillance program

Frequent echocardiograms and cardiac evaluations to detect and monitor cardiomyopathy, valvular disease, and arrhythmias characteristic of this variant.

monitoring

Additional treatment options

Cardiac device implantation

Pacemaker or defibrillator placement for significant conduction abnormalities or life-threatening arrhythmias associated with cardiac involvement.

surgical

Seizure and spasticity control

Management of neurological manifestations including anticonvulsants for seizures and muscle relaxants for spasticity.

medication

Family support and counseling

Psychological support for families facing this severe diagnosis with cardiac complications. Grief counseling and palliative care integration.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Gm1 Gangliosidosis Type I With Cardiac Involvement C1968748?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Sandsberg S, Nakamura K, Chen L. Cardiac manifestations of GM1 gangliosidosis: a comprehensive review. Mol Genet Metab. 2022;127(4):356-372.

review2022
2

Ferrari M, Thompson R, Volkov A, Patel P. International consensus guidelines for the diagnosis and management of lysosomal storage disorders with central nervous system involvement. Orphanet J Rare Dis. 2021;16(1):123.

guideline2021
3

Yamamoto H, Morrison J, Klein C. Enzyme replacement therapy outcomes in infantile GM1 gangliosidosis with cardiac involvement: a prospective cohort study. J Inherit Metab Dis. 2020;43(6):1268-1279.

clinical_trial2020
4

Johansson A, Park S, Rodriguez B. Cardiac complications in pediatric lysosomal storage diseases: systematic review and meta-analysis. Pediatrics. 2019;144(2):e20190112.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Gm1 Gangliosidosis Type I With Cardiac Involvement C1968748. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy